1. Home
  2. BOLD vs BGI Comparison

BOLD vs BGI Comparison

Compare BOLD & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • BGI
  • Stock Information
  • Founded
  • BOLD 2018
  • BGI 1879
  • Country
  • BOLD United States
  • BGI Canada
  • Employees
  • BOLD N/A
  • BGI N/A
  • Industry
  • BOLD
  • BGI
  • Sector
  • BOLD
  • BGI
  • Exchange
  • BOLD Nasdaq
  • BGI Nasdaq
  • Market Cap
  • BOLD 25.5M
  • BGI 22.7M
  • IPO Year
  • BOLD 2024
  • BGI 2005
  • Fundamental
  • Price
  • BOLD $1.22
  • BGI $1.15
  • Analyst Decision
  • BOLD Buy
  • BGI
  • Analyst Count
  • BOLD 4
  • BGI 0
  • Target Price
  • BOLD $4.00
  • BGI N/A
  • AVG Volume (30 Days)
  • BOLD 120.5K
  • BGI 3.3M
  • Earning Date
  • BOLD 11-06-2025
  • BGI 11-26-2025
  • Dividend Yield
  • BOLD N/A
  • BGI N/A
  • EPS Growth
  • BOLD N/A
  • BGI N/A
  • EPS
  • BOLD N/A
  • BGI N/A
  • Revenue
  • BOLD N/A
  • BGI $124,446,731.00
  • Revenue This Year
  • BOLD N/A
  • BGI N/A
  • Revenue Next Year
  • BOLD N/A
  • BGI N/A
  • P/E Ratio
  • BOLD N/A
  • BGI N/A
  • Revenue Growth
  • BOLD N/A
  • BGI N/A
  • 52 Week Low
  • BOLD $1.00
  • BGI $0.56
  • 52 Week High
  • BOLD $3.75
  • BGI $2.31
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 63.15
  • BGI 61.02
  • Support Level
  • BOLD $1.10
  • BGI $1.00
  • Resistance Level
  • BOLD $1.25
  • BGI $1.23
  • Average True Range (ATR)
  • BOLD 0.05
  • BGI 0.12
  • MACD
  • BOLD 0.01
  • BGI -0.01
  • Stochastic Oscillator
  • BOLD 75.00
  • BGI 41.59

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

Share on Social Networks: